Latest Abbott Laboratories Stories
LONDON, July 16, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
- Second-Quarter Ongoing EPS of $0.54, Above Previous Guidance Range and Representing Double-Digit Earnings-Per-Share Growth - ABBOTT PARK, Ill., July 16, 2014 /PRNewswire/ -- Abbott today
Abbott will retain its branded generics pharmaceuticals business in emerging markets ABBOTT PARK, Ill., July 14, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that it will
RnRMarketResearch.com adds “World Glucose Self-Testing Markets” and “U.S. Glucose Testing Markets” to its store.
Global IVD Market 2014-2018, A New Research Report, Added to Sandlerresearch.org Store Dallas, Texas (PRWEB) July 06, 2014 In the recent past, there
DUBLIN, July 2, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/8nwszl/pointofcare)
LONDON, June 26, 2014 /PRNewswire/ -- On Monday, the American healthcare corporation Abbott Laboratories announced the purchase of the Russian pharmaceutical company Veropharm.
The molecular diagnostics market is categorized on the basis of application, technology, end user, product, and geography.
The emerging markets including China, India, Brazil, and Mexico have become attractive for the companies engaged in the development and marketing of the hematology analyzers and reagents -
DALLAS, June 17, 2014 /PRNewswire/ -- According to new Market Research Report "Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology),
- A serpent whose bite was fabled to produce intense thirst.